Jubilant Pharmova Ltd

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd has announced its 48th Annual General Meeting (AGM) to be held on August 26, 2026, through video conferencing. The company has also released its annual report for the financial year 2025-26 and has proposed a dividend of ₹5 per equity share.

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd has submitted copies of newspaper advertisements relating to notice to shareholders regarding the transfer of equity shares/dividend to the Investor Education and Protection Fund Authority.

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd has announced a company update under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the transfer of unclaimed dividend and equity shares to the Investor Education and Protection Fund (IEPF). The company has sent a communication to shareholders informing them of the transfer and providing details of the unpaid dividend and shares to be transferred. Shareholders are requested to claim the unpaid dividend by making an application to Alankit Assignments Limited before August 31, 2026, to avoid the transfer of shares to the IEPF.

Jubilant Pharmova Ltd

Jubilant Pharmova Ltd announced the 48th Annual General Meeting (AGM) scheduled for August 26, 2026, through video conferencing. The notice and annual report for 2025-26 will be sent to shareholders via email and available on the company's website.